Ultralife CORP

Ultralife Corporation's 2026 Annual Meeting saw the election of five directors, ratification of auditors, and approval of executive compensation, with a preference for triennial advisory votes.

Ultralife Corporation announced first quarter 2026 results showing a year-over-year decrease in sales and profitability, impacted by operational disruptions and weak Communications Systems sales, though backlog reached a record high.

Ultralife Corporation reported a 21.5% revenue increase to $43.4 million in Q3 2025, but posted an operating loss of $1.0 million due to one-time costs and operational inefficiencies.

Ultralife Corporation has appointed Withum Smith+Brown as its new independent registered public accounting firm, replacing Freed Maxick P.C. due to an acquisition.

Ultralife Corporation reported a 13% increase in second-quarter sales to $48.6 million, driven by an acquisition, but faced significant declines in profitability and Communications Systems sales.

Ultralife Corporation announced the successful election of its five directors and the ratification of Freed Maxick P.C. as its independent registered public accounting firm for 2025 at its 2025 Annual Meeting of Stockholders.

Ultralife Corporation reported a 6.5% decrease in revenue for the first quarter of 2026 compared to the prior year, driven by declines in both commercial and government/defense sales.

Ultralife Corporation reported a net loss for Q3 2025, driven by increased operating expenses, higher interest costs from its Electrochem acquisition, and declining gross margins, despite overall revenue growth.

Ultralife Corporation reported a significant decline in second-quarter net income and EPS despite revenue growth driven by its recent Electrochem acquisition, facing increased operating expenses and interest costs.

Ultralife Corporation's Q1 2025 revenue increased by 21% year-over-year, primarily due to the acquisition of Electrochem and growth in government/defense sales, though profitability was impacted by sales mix and increased operating expenses.

Ultralife Corporation's Q3 2024 results show a revenue decrease and increased operating expenses, alongside the strategic acquisition of Electrochem Solutions, Inc.

Ultralife Corporation's Q2 2024 results show a slight revenue increase and improved gross profit, driven by strong performance in the Battery & Energy Products segment.

Ultralife Corporation has filed an amendment to its Form 10-K for the fiscal year ended December 31, 2025, to include omitted Part III information.

Ultralife Corporation reported a net loss of $5.9 million for 2025, driven by a significant non-cash intangible asset impairment from a global rebranding initiative, despite robust revenue growth and record backlog in its Battery & Energy Products segment.

Ultralife Corporation files an amendment to its annual report on Form 10-K to include information on directors, executive officers, corporate governance, and executive compensation.

Ultralife Corporation's FY 2024 results show revenue growth driven by the Battery & Energy Products segment, offset by a decline in Communications Systems sales.

Ultralife Corporation has filed an amendment to its annual report to include previously omitted information regarding directors, executive compensation, and corporate governance.

Ultralife Corporation's annual report reveals a 20.3% increase in revenue for fiscal year 2023, driven by growth in both Battery & Energy Products and Communications Systems segments.

Bradford T. Whitmore, a Director and 10% Owner of Ultralife Corp, has reported multiple purchases of the company's common stock between May 21 and May 26, 2026.

Michael Manna, President and CEO of Ultralife Corp, has acquired 2,000 shares of common stock.

ULTRALIFE Corp. Director and 10% owner Bradford T. Whitmore acquired 187,512 shares of common stock through indirect holdings in mid-March 2026.

ULTRALIFE CORP's President and CEO, Michael Edward Manna, increased his direct beneficial ownership by purchasing 2,000 shares of common stock.

ULTRALIFE Director Bradford T. Whitmore reports changes in indirect beneficial ownership, including a transfer of shares from Grace Brothers, LP to Whitmore Holdings, LLC.

ULTRALIFE Corp. Director and 10% owner Bradford T. Whitmore increased his indirect beneficial ownership through recent stock purchases.

Ultralife Corporation announces its 2026 Annual Meeting of Stockholders, scheduled for July 22, 2026, to elect directors, ratify auditors, and vote on executive compensation.

Ultralife Corporation has filed definitive additional proxy materials (DEFA14A) with the U.S. Securities and Exchange Commission.

Ultralife Corporation has announced its 2025 Annual Meeting of Stockholders to be held on July 16, 2025, where shareholders will vote on director elections and auditor ratification, alongside disclosures on executive compensation and corporate governance.

Ultralife Corporation has filed a definitive proxy statement with the SEC, signaling upcoming shareholder actions.

Ultralife Corporation is asking stockholders to approve the Ultralife Corporation 2024 Long-Term Incentive Plan (New LTIP) at the upcoming annual meeting on July 16, 2024.

Bradford T. Whitmore and affiliated entities increased their beneficial ownership in Ultralife Corp to 39.6% through recent share purchases.

Visionary Wealth Advisors has reported a 6.6% beneficial ownership stake in Ultralife Corp, holding 1,090,207 shares of common stock.

Visionary Wealth Advisors, LLC has filed a Schedule 13G, reporting a beneficial ownership of 7.8% of ULTRALIFE CORP's common stock as of December 31, 2024.